Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Enterprise Value: 2009-2020

Historic Enterprise Value for Neurocrine Biosciences (NBIX) over the last 12 years, with Dec 2020 value amounting to $8.2 billion.

  • Neurocrine Biosciences' Enterprise Value rose 3.60% to $8.3 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $5.7 billion, marking a year-over-year increase of 2.07%. This contributed to the annual value of $8.2 billion for FY2020, which is 11.68% down from last year.
  • According to the latest figures from FY2020, Neurocrine Biosciences' Enterprise Value is $8.2 billion, which was down 11.68% from $9.2 billion recorded in FY2019.
  • Neurocrine Biosciences' Enterprise Value's 5-year high stood at $9.2 billion during FY2019, with a 5-year trough of $3.1 billion in FY2016.
  • In the last 3 years, Neurocrine Biosciences' Enterprise Value had a median value of $8.2 billion in 2020 and averaged $7.7 billion.
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 32.07% in 2016, then spiked by 107.89% in 2017.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' Enterprise Value stood at $3.1 billion in 2016, then soared by 107.89% to $6.4 billion in 2017, then fell by 8.28% to $5.8 billion in 2018, then spiked by 58.44% to $9.2 billion in 2019, then declined by 11.68% to $8.2 billion in 2020.